相关实验视频
Updated: Jan 16, 2026
05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.8K
循环RNA蛋白替代疗法可减轻雄性小鼠的骨关节炎
Jinlong Suo1, Ling Li2,3, Wuyuan Tan4,5,6
1Institute of Microsurgery on Extremities, and Department of Orthopedic Surgery Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, 200233, China. suojinlong2015@sibcb.ac.cn.
Nature communications
|September 26, 2025
概括
在体外转录和循环RNAs (ivcRNAs) 提供了一种新的方法来治疗关节炎,通过替代关节细胞中缺少的蛋白质. 这种RNA疗法在小鼠模型中有效降低了骨关节炎的进展.
科学领域:
- 生物化学和分子生物学
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种常见的退行性关节疾病,治疗选择有限.
- 关节性冠状细胞中的Musashi2 (Msi2) 缺乏被确定为OA发病的关键因素.
- 目前的OA治疗重点是症状管理,而不是疾病修改.
研究的目的:
- 为了研究体外转录和循环RNAs (ivcRNAs) 对于持续的蛋白质翻译在chondrocytes中的潜力.
- 为了评估IVcRNA介导的骨关节炎蛋白替代疗法.
- 评估MSI2和SOX5蛋白质补充剂通过IVcRNA输送在OA小鼠模型中的治疗疗效.
主要方法:
- 使用ivcRNAs开发一种局部传递策略,用于使用ivcRNAs在软细胞中产生高产量,长时间的蛋白质表达.
- 利用中介半月 (DMM) 鼠标模型的不稳定来模拟OA的进展.
- 编码Musashi2 (MSI2) 和SOX5.5的IVcRNA的关节内输送.
主要成果:
- ivcRNA的输送使得冠状细胞中持续的蛋白质表达成为可能.
- 在雄性小鼠中,对编码MSI2的IVcRNA进行关节内注射显著减轻了OA的进展.
- 通过IVcRNA输送对SOX5的治疗补充进一步验证了这一方法.
结论:
- 冠状细胞中的Msi2缺乏导致了OA的发病.
- 基于ivcRNA的蛋白质替代疗法是局部治疗骨关节炎的一个有前途的策略.
- 这种RNA治疗方法有可能在OA中改变疾病.
相关概念视频
02:15Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
01:23RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K